THE WHAT? Procter & Gamble is set to buy Tula Skincare, its third such acquisition in the space of three months, according to a report published by WWD. Terms of the deal were not disclosed.
THE DETAILS The superfood-based line is said to have bought in US$150 million in sales last year. The US FMCG giant will add the wellbeing brand to its existing, and fast-growing prestige portfolio, which includes SK-II, First Aid Beauty, Ouai hair care and Farmacy Beauty.
THE WHY? Markus Strobel, President of Global Skin and Personal Care at P&G told WWD, “When we look at our beauty strategy, we want to win in beauty in the categories we choose to play in – skin, hair and personal care, categories where the clinical performance of the products make a difference. We want to win in the industry – in different channels and segments. Wherever we feel that there is a gap in our portfolio, then we want to close it.
“The prestige beauty channel is growing double digits so it is a channel where we want to have a stronger presence with a tight portfolio. A portfolio that covers the key benefit spaces that we feel will be growing in the future.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
